ARS Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 64.7% | 64.7% | -32.9% |
| FY2022 | -12.7% | -12.7% | -12.3% |
| FY2023 | -23.6% | -23.6% | -23.3% |
| FY2024 | 3.1% | 3.1% | 2.3% |
| FY2025 | -149.9% | -81.3% | -52.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 64.7% | 64.7% | -32.9% |
| FY2022 | -12.7% | -12.7% | -12.3% |
| FY2023 | -23.6% | -23.6% | -23.3% |
| FY2024 | 3.1% | 3.1% | 2.3% |
| FY2025 | -149.9% | -81.3% | -52.3% |